BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-813@pharmaconomics
DTSTAMP:20260707T030808Z
DTSTART;VALUE=DATE:20260331
DTEND;VALUE=DATE:20260401
SUMMARY:CMPS Phase 3 — COMP006
DESCRIPTION:Phase 3 trial results for COMP006 in treatment-resistant depression (TRD) are due Mar 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1816590/000181659026000043/q12026pressrelease.htm\n\nTrack it: https://pharmaconomics.com/e/813
URL:https://pharmaconomics.com/e/813
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CMPS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR